July 23, 2017 3:32 AM ET

Biotechnology

Company Overview of Melinta Therapeutics, Inc.

Key Executives for Melinta Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Eugene Sun M.D.6 RelationshipsChief Executive Officer and Director57
John Temperato No RelationshipsPresident and Chief Operating Officer--
William L. Jorgensen Ph.D.23 RelationshipsCo-Founder--
Peter B. Moore Ph.D.No RelationshipsCo-Founder--
Harry H. Penner Jr., J.D., L.L.M.36 RelationshipsCo-Founder72
View More Key Executives

Melinta Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Thomas Paul Koestler Ph.D. 44 RelationshipsVatera Healthcare Partners66
Eugene Sun M.D. 6 RelationshipsMelinta Therapeutics, Inc.57
John Edward Sununu 54 RelationshipsBoston Scientific Corporation52
Kevin Thomas Ferro 26 RelationshipsFerro Capital LLC46
Sundar Kodiyalam 29 RelationshipsVatera Healthcare Partners--
View All Board Members

Melinta Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
392.3K
Bonus
238.3K
Total Short Term Compensation
487.5K
Total Value of Options
18.4M
Compensation as of Fiscal Year
Melinta Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Neurocrine Biosciences Announces the Appointment of Julie Cooke as Chief People Officer
July 21, 2017 1:28 PM ET
Valens GroWorks Corp. Appoints Saul Katz as President
July 21, 2017 4:19 AM ET
Aeterna Zentaris Inc. Announces Executive Changes
July 20, 2017 9:00 PM ET
Aeglea BioTherapeutics, Inc. Announces Executive Changes
July 20, 2017 8:01 PM ET
Trevena, Inc. Announces the Resignation of David Soergel as Chief Medical Officer
July 20, 2017 7:33 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Melinta Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.